Cannabist Company
Multi-state cannabis operator (formerly Columbia Care) with operations across multiple US markets.
Analyst Coverage
Cannabis Investor News in-house rating · cin-analyst-v1.0
The Cannabist Company Holdings carries a Neutral rating, with a composite score of 38 out of 100 and a conviction reading of 3 of 5. Four pillars feed the composite in fixed weights (35/25/25/15 for fundamentals, regulatory, market, and editorial), and no clause of the score is hidden from the reader. Regulatory carries this profile, printing 49 and setting the ceiling on the composite. The editorial pillar sits at 30, and is the main drag on the composite.
The scoring inputs are concrete: reported revenue growth of -30.4 percent year over year, an operating margin of -15.0 percent, a market cap near 14 million, a jurisdictional posture reading of 50. Together they explain most of the pillar mix. The scoring pipeline pulls only from primary regulatory filings, licensed fundamentals data, institutional pricing feeds, and CIN newsroom coverage, and each pillar exposes its own inputs. This lets The Cannabist Company Holdings be lined up against the US operator peer set on identical inputs, with refresh cadence tied directly to primary-source ingest.
Filing cadence and jurisdictional posture remain the primary drivers, with regulatory contributing 49. A sustained lift in filing frequency across the trailing 90 days combined with zero enforcement events would tighten the Neutral conclusion.
- IR email
- investor@cannabistcompany.com
- IR page
- Investor relations
- CEO
- David Hart
- CFO
- Derek Watson
- SEC CIK
- 0001776738
- Website
- Company website
- Market cap
- $14.5M
- Enterprise value
- $439.8M
- Price to book
- 4.56
- Price to sales
- 0.04
- EV / EBITDA
- -12.99
- Revenue (TTM)
- $349.8M
- Gross profit (TTM)
- $103.2M
- EBITDA
- $-13.1M
- Operating margin
- -15.0%
- Profit margin
- -51.1%
- Rev growth YoY
- -30.4%
- Return on equity
- -595.7%
- Return on assets
- -4.6%
- EPS (TTM)
- $-0.38
- EPS est. current year
- $-0.29
- Wall St. target price
- $0.63
- Shares outstanding
- 490.1M
- Insider ownership
- 5.2%
- Institutional ownership
- 14.5%
- Beta
- 0.75
- Full-time employees
- 1,681
- GICS sector
- Healthcare
- GICS industry
- Drug Manufacturers - Specialty & Generic
- Filing portal
- SEC EDGAR
Help us keep coverage accurate. Submit an update for CIN editorial review.
Bullish and Bearish Analyst Opinions for Cannabist Company (CBSTF)
Cannabis Investor News aggregates analyst coverage, price targets, insider transactions, SEC filings, and financing activity for Cannabist Company (CBSTF), a cannabis-sector equity listed on OTCMKTS in the US MSO category. Use this profile to compare bullish and bearish opinions, monitor Form 4 insider buys and sells, and review the latest quarterly results.
CIN editorial stance: Risk Elevated. Headwinds: deep drawdown, net loss. (1 bullish signal, 3 bearish signals.)
Multi-state cannabis operator (formerly Columbia Care) with operations across multiple US markets.
Historical Price Data
5-year weekly price history, intraday quotes, and 52-week range for CBSTF are maintained by Cannabis Investor News and refreshed throughout the trading day.